- Report
- January 2024
- 120 Pages
Global
From €7602EUR$7,950USD£6,514GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Drug Pipelines
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Drug Pipelines
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- November 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €3108EUR$3,250USD£2,663GBP
- Report
- April 2023
- 120 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- January 2024
- 164 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- December 2023
- 162 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- January 2024
- 120 Pages
Global
From €7602EUR$7,950USD£6,514GBP
- Drug Pipelines
- November 2023
- 200 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- February 2024
- 115 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- April 2023
- 111 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- December 2023
- 163 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- April 2023
- 110 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
The Kinase market is a subset of the Drug Discovery market, focusing on the development of drugs that target kinases, a type of enzyme that plays a role in many cellular processes. Kinase inhibitors are used to treat a variety of diseases, including cancer, diabetes, and neurological disorders. Kinase inhibitors are typically small molecules that bind to the active site of the kinase, blocking its activity.
Kinase inhibitors are developed through a combination of in vitro and in vivo assays, as well as computational modeling. Companies in the Kinase market are focused on developing novel inhibitors that can be used to treat a variety of diseases. These companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more